Suppr超能文献

肝硬化患者的心脏移植

Heart transplantation in patients with liver cirrhosis.

作者信息

Hsu Ron-Bin, Chang Chung-I, Lin Fang-Yue, Chou Nai-Kuan, Chi Nai-Hsin, Wang Shoei-Shen, Chu Shu-Hsun

机构信息

Department of Surgery, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan, ROC.

出版信息

Eur J Cardiothorac Surg. 2008 Aug;34(2):307-12. doi: 10.1016/j.ejcts.2008.05.003. Epub 2008 Jun 6.

Abstract

OBJECTIVE

Liver cirrhosis is considered to be a contraindication to heart transplantation. However, the clinical outcome of heart transplantation in patients with liver cirrhosis has not been reported. Here, we sought to evaluate the clinical outcome of heart transplantation in cirrhotic patients.

METHODS

Data were collected by retrospective chart review. Patients with liver cirrhosis at the time of transplantation were included.

RESULTS

Between 1987 and 2007, 12 patients with liver cirrhosis underwent heart transplantation at the authors' hospital. Diagnosis of liver cirrhosis was based on preoperative abdominal sonography in five, autopsy in five, and laparotomy in two patients. Causes of heart failure were dilated cardiomyopathy in four, coronary artery disease in three, congenital heart disease in three and valvular heart disease in two patients. Causes of liver cirrhosis were alcoholism in two, cardiac in seven, and unknown in three patients. The Child classification was class A in three, class B in five and class C in four patients. Overall, the hospital mortality rate was 50% and major in-hospital complications occurred in nine patients (75%). Patients with non-cardiomyopathy diagnosis, previous sternotomy, and massive ascites had a high hospital mortality rate. The median follow-up duration was 33.5 months. There was no late death. Late post-transplant complications occurred in four patients and there was no event of liver dysfunction. All survivors were in Child class A at outpatient follow-up.

CONCLUSIONS

Although there was high mortality and morbidity, patients with end-stage heart failure and liver cirrhosis can be considered for heart transplantation with careful case selection.

摘要

目的

肝硬化被认为是心脏移植的禁忌证。然而,肝硬化患者心脏移植的临床结果尚未见报道。在此,我们旨在评估肝硬化患者心脏移植的临床结果。

方法

通过回顾性病历审查收集数据。纳入移植时患有肝硬化的患者。

结果

1987年至2007年期间,作者所在医院有12例肝硬化患者接受了心脏移植。肝硬化的诊断依据为5例术前腹部超声检查、5例尸检以及2例剖腹手术。心力衰竭的病因包括4例扩张型心肌病、3例冠状动脉疾病、3例先天性心脏病和2例心脏瓣膜病。肝硬化的病因包括2例酒精性、7例心源性和3例病因不明。根据Child分级,3例为A级,5例为B级,4例为C级。总体而言,医院死亡率为50%,9例患者(75%)发生了主要的院内并发症。非心肌病诊断、既往胸骨切开术和大量腹水的患者医院死亡率较高。中位随访时间为33.5个月。无晚期死亡。4例患者发生了移植后晚期并发症,未出现肝功能障碍事件。所有存活患者在门诊随访时均为Child A级。

结论

尽管死亡率和发病率较高,但对于终末期心力衰竭合并肝硬化的患者,经过仔细的病例选择,可考虑进行心脏移植。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验